��Ƶ

��Ƶ" data-color="d85229">Multi-billion global AI spending transforming business efficiency, SDAIA official tells Riyadh conference
Middle-East" data-color="d85229">Argentina withdraws from UN peacekeeping mission in Lebanon
Middle-East" data-color="d85229">Italy says Hezbollah staged UN base attack it had blamed on Israel
��Ƶ" data-color="d85229">Climate change is a key driver of worldwide hunger, according to IFAD
��Ƶ" data-color="d85229">Al-Baha farms offer an escape from busy lives
Sport" data-color="d85229">��Ƶ’s World Cup hopes dented in Indonesia
��Ƶ" data-color="d85229">Forum focuses on women’s role in Saudi economy
Middle-East" data-color="d85229">Israeli settler group slams US sanctions over West Bank
Business & Economy" data-color="d85229">Developing nations push for action on COP29 financing shortfalls
Middle-East" data-color="d85229">French minister on Gulf tour says Lebanon’s army needs support

Japan in deal to purchase AstraZeneca’s COVID-19 vaccine

Japan is bracing for a looming second wave of coronavirus infections. (AP)

Short Url

https://arab.news/g9qbw

Updated 07 August 2020

Reuters

August 07, 2020 09:28

Japan in deal to purchase AstraZeneca’s COVID-19 vaccine

Japan announced a deal last week to buy 120 million doses of a COVID-19 vaccine candidate developed by Pfizer and BioNTech

Updated 07 August 2020

Reuters

August 07, 2020 09:28

TOKYO: Japan has agreed to acquire 120 million doses of AstraZeneca’s experimental COVID-19 vaccine if it is successfully developed, the health minister said on Friday.
The agreement comes after Japan announced a deal last week to buy 120 million doses of a COVID-19 vaccine candidate developed by Pfizer Inc. and BioNTech.